Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sjogren syndrome: an explanatory interventional study.
d'Elia
H Forsblad
HF
Bjurman
C
C
Rehnberg
E
E
Kvist
G
G
Konttinen
Y T
YT
D000328:Adult; D000368:Aged; D019314:Dehydroepiandrosterone Sulfate / Q000627:therapeutic use*; D004311:Double-Blind Method; D005221:Fatigue / Q000188:drug therapy; D005260:Female; D020249:Hormone Replacement Therapy; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology; D015850:Interleukin-6 / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D010913:Pituitary-Adrenal System / Q000503:physiopathology; D019947:Receptors, Interleukin-6 / Q000502:physiology*; D012859:Sjogren's Syndrome / Q000188:drug therapy*
D015850:Interleukin-6; D019947:Receptors, Interleukin-6; D019314:Dehydroepiandrosterone Sulfate